Recurrent Pregnancy Loss in Haryana: Causes, Diagnosis & How HomeIVF Can Help

Recurrent pregnancy loss is defined by most international bodies, including the ESHRE and ASRM, as two or more clinical pregnancy losses before 20 weeks of gestation. In India, many clinicians use the traditional threshold of three or more losses, but the trend has shifted toward investigating after two, particularly in women over 35 or those with a single live birth between losses.

In Haryana, the burden of RPL is shaped by a unique combination of factors: a relatively high rate of consanguineous marriages in some communities, widespread nutritional deficiencies including folate and vitamin D, undiagnosed thyroid disorders — which are particularly prevalent among women in peri-urban areas like Faridabad and Rohtak — and delayed presentation due to stigma around reproductive health. Many couples in semi-urban towns such as Panipat or Ambala silently endure two or three losses before consulting a specialist, by which time treatable causes have been present for years.

National registry data suggests that roughly 1 in 50 to 1 in 100 couples attempting to conceive will experience RPL. Given Haryana's population of over 28 million with a relatively young demographic profile, the absolute number of affected couples running into tens of thousands is a conservative estimate. Early diagnosis and systematic evaluation remain the most powerful tools available.

Understanding why RPL happens is the first step toward fixing it. The causes are broadly classified into genetic, anatomical, immunological, thrombophilic, endocrine, and unexplained categories — and in many couples, more than one factor coexists.

Genetic factors are the single largest contributor. Embryonic chromosomal aneuploidy — having too many or too few chromosomes — accounts for the majority of first-trimester losses. In older women, this is predominantly due to age-related decline in egg quality. Parental chromosomal rearrangements such as balanced translocations are rarer but important because they recur predictably.

Anatomical abnormalities of the uterus — including a septate uterus, submucous fibroids, intrauterine adhesions (Asherman's syndrome), or a unicornuate uterus — physically impair implantation or placental development. These structural issues are correctable with hysteroscopic surgery in most cases.

Immunological causes, particularly antiphospholipid syndrome (APS), are among the most clinically important treatable causes of RPL. APS causes recurrent thrombosis in placental vessels, cutting off fetal blood supply. Maternal immune rejection mechanisms and natural killer cell imbalances are also under active investigation.

Endocrine disorders — poorly controlled diabetes, thyroid dysfunction (both hypothyroidism and subclinical thyroid autoimmunity), hyperprolactinaemia, and polycystic ovary syndrome (PCOS) — are disproportionately common among Haryana women and all independently raise miscarriage risk. In cities like Gurgaon and Faridabad, lifestyle-driven metabolic disorders add another layer of complexity.

The clinical presentation of a miscarriage — vaginal bleeding, cramping, and passage of tissue — is usually unmistakable. However, RPL often involves a pattern that couples and sometimes even primary care providers fail to connect across time. A miscarriage at 8 weeks, followed by a biochemical pregnancy (positive test, early loss before a heartbeat is seen) a year later, and then another loss at 10 weeks — each event may be coded as an isolated incident rather than a recurring pattern demanding investigation.

Physically, warning signs that the current pregnancy may be at risk include slow-rising or falling beta-hCG levels in early pregnancy, absent or weak fetal heartbeat at the gestational age when it should be detectable, and subchorionic haemorrhage on ultrasound. Women with known APS may experience unusually early-onset preeclampsia or fetal growth restriction in pregnancies that do progress.

Emotionally, the toll of RPL is profound. Anxiety, depression, grief, relationship strain, and social isolation are near-universal among RPL couples. In Haryana's social fabric, where extended family involvement in reproductive matters is the norm, the pressure compounds the psychological burden. HomeIVF's model includes access to counselling support alongside medical care, recognising that treating the whole person — not just the uterus — produces better outcomes. Couples should not wait for a third loss to seek help; two consecutive losses justify a full evaluation.

A systematic RPL investigation should be comprehensive and standardised. The HomeIVF Medical Board recommends the following evidence-based panel for all couples presenting with two or more losses.

Genetic testing includes karyotyping of both partners to identify balanced chromosomal rearrangements. Where possible, products of conception from the most recent miscarriage should be sent for chromosomal microarray analysis — this single test can determine within days whether the loss was due to embryonic aneuploidy, sparing couples months of unnecessary investigations.

Uterine assessment is best performed by 3D transvaginal ultrasound or saline infusion sonohysterography (SIS), which can delineate a uterine septum from an arcuate uterus, identify polyps, and assess the endometrial lining. Hysteroscopy remains the gold standard for simultaneous diagnosis and treatment of intrauterine pathology.

Immunological and thrombophilic panels include anticardiolipin antibodies, lupus anticoagulant, anti-beta-2 glycoprotein antibodies (for APS diagnosis), and inherited thrombophilia screening (Factor V Leiden, prothrombin gene mutation, MTHFR).

Endocrine tests cover TSH with anti-TPO antibodies, fasting glucose and insulin, HbA1c, prolactin, and AMH. In women with PCOS — which is highly prevalent across Haryana — LH, FSH, and androgen levels complete the picture.

HomeIVF coordinates sample collection at home, with courier logistics to accredited laboratories, so couples in Karnal, Sonipat, or Rewari do not need to visit a clinic for phlebotomy.

Treatment for RPL is cause-directed, which is precisely why the diagnostic workup matters so deeply. There is no single universal protocol — what works for a couple in Gurgaon with antiphospholipid syndrome will differ entirely from the approach for a couple in Panipat with a uterine septum.

For antiphospholipid syndrome, the combination of low-dose aspirin started pre-conceptionally and low-molecular-weight heparin (LMWH) from the time of a positive pregnancy test through the first trimester has been shown in randomised trials to increase live birth rates by approximately 50-70% compared with no treatment. This protocol is manageable at home with proper injection training, which HomeIVF nurses provide during home visits.

Hysteroscopic resection of a uterine septum dramatically reduces RPL risk in women with this anatomical variant. Post-operatively, the endometrium is allowed to heal over one to two menstrual cycles before conception is attempted.

For couples with chromosomal rearrangements or advanced maternal age driving aneuploidy-related losses, IVF with preimplantation genetic testing for aneuploidies (PGT-A) is the most effective intervention. By selecting only chromosomally normal embryos for transfer, the per-transfer miscarriage rate drops substantially. HomeIVF facilitates access to IVF packages starting from ₹1.5 lakh, making this technology accessible to Haryana couples who might otherwise assume it is out of reach.

Thyroid autoimmunity is managed with levothyroxine to keep TSH below 2.5 mIU/L during conception and early pregnancy. Progesterone supplementation in the luteal phase and early pregnancy is widely prescribed and, while evidence for unexplained RPL is still evolving, it carries minimal risk and may benefit a subset of women with luteal phase insufficiency.

One of the most significant barriers for RPL couples across Haryana has historically been geography. While Gurgaon has access to tertiary fertility centres, couples in towns like Jhajjar, Fatehabad, or Sirsa often face four-to-six-hour round trips for a single blood test result review or progesterone check. This friction causes delayed treatment initiation, missed monitoring windows, and ultimately worse outcomes.

HomeIVF was built specifically to dismantle these barriers. Through a combination of home-visit nurses, tele-consultation with senior fertility specialists reviewed by the HomeIVF Medical Board, home-based hormone monitoring, and digital-first care coordination, the platform delivers the same quality of care that was previously available only in premium urban clinics — directly to your home in Haryana.

For RPL patients specifically, the model is transformative. Early pregnancy monitoring — serial beta-hCG measurements, progesterone levels, and early viability scans coordinated through HomeIVF's partner sonography network — can be conducted without disrupting work schedules or requiring stressful long-distance travel. Injection training for heparin or progesterone pessary guidance is delivered at home by trained clinical staff. All results are reviewed by senior specialists who flag concerns within 24 hours.

The emotional dimension is also addressed: HomeIVF's RPL care pathway includes scheduled counselling touchpoints, because research consistently shows that psychological support improves treatment adherence and, independently, may improve outcomes in unexplained RPL.

One of the first questions couples ask after two or more losses is: how long will this take, and what will it cost? While exact costs vary based on tests required and treatment chosen, the RPL diagnostic workup — including genetic karyotyping for both partners, immunological panel, uterine assessment, and endocrine screening — typically takes four to six weeks from initiation to a comprehensive results review.

Treatment timelines depend heavily on what is found. Correcting thyroid dysfunction and retrying naturally may take only one to two menstrual cycles. Hysteroscopic surgery requires a recovery cycle. IVF with PGT-A, from stimulation to frozen embryo transfer, typically spans two to three months. Throughout this process, HomeIVF's care coordinators in Haryana manage scheduling, logistics, and communication, so couples are not left navigating a fragmented system alone.

For couples who require IVF as part of their RPL management, HomeIVF offers packages starting from ₹1.5 lakh — a significant departure from the opacity that often characterises fertility clinic pricing in Haryana. The RPL diagnostic panel is priced separately and transparently, with no hidden consultation fees.

Many couples in Faridabad and Karnal have found that consolidating their RPL care under a single coordinated platform — rather than visiting three separate specialists — saves both money and time, while improving the coherence of their treatment plan.

Beyond geography, Haryana couples face several structural and cultural barriers that delay appropriate RPL care. Stigma around repeated pregnancy loss — sometimes attributed to fate, spiritual causes, or even blamed on the woman — discourages early help-seeking. Many couples invest months or years in alternative treatments before presenting to a fertility specialist, by which time the woman's ovarian reserve may have declined further.

Language and literacy barriers mean that complex investigation results are often not fully understood by patients who consult in overly clinical environments. HomeIVF's care pathway in Haryana includes Hindi-medium communication, simplified result explanations, and dedicated care coordinators who are reachable by phone and WhatsApp — not just during clinic hours.

For working couples in Gurgaon or Faridabad, taking repeated half-days off for monitoring appointments is practically difficult and financially costly. HomeIVF's home-visit model eliminates this friction entirely.

Finally, the lack of integrated mental health support within conventional RPL pathways in Haryana means that grief and anxiety go unaddressed, undermining treatment compliance. HomeIVF's holistic RPL programme treats psychological wellbeing as a clinical priority, not an afterthought, bridging a gap that has long existed in the region's fertility care landscape.